Kenya was hit hard by the HIV/AIDS epidemic, with an HIV prevalence rate of about 6 percent. In support the Kenyan government’s efforts to fight HIV/AIDS, Pharma established a pharmaceutical supply chain management system that improved forecasting and planning commodity procurement needs, reduced costs, increases local resources for quality assurance, and ensured that supplies reach remote areas.
The USAID-funded project played a major role in U.S. government efforts to scale-up its provision of the drugs, supplies, and equipment needed for HIV/AIDS care and treatment in Kenya. Through Pharma, Chemonics delivered drugs, supplies, and equipment to HIV/AIDS programs funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). To increase efficiency and transparency, Chemonics also created a web-based information system that provides time and cost savings for the project and the larger PEPFAR initiative.
- Zero stockouts in the last four years of Kenya Pharma (46.2 percent of service delivery points experienced stockout in the year before the project began)
- 416,711 people living with HIV/AIDS treated with anti-retrovirals (ARVs)
- 832,488 people living with HIV/AIDS treated for opportunistic infections
- 32,269 pregnant women treated to prevent mother-to-child transmission
- 26,066 infants treated to limit mother-to-child transmission
Project Duration: 2009 - 2015